Proem Advisors’s Oracle ORCL Stock Holding History

Proem Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90,000	Closed	-$25.3M	–	48
2025 Q3	$25.3M	Buy	+90,000	New	+$22.9M	2.69%	12

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Proem Advisors's ORCL Position: Q2 2026 in Review

Proem Advisors sold out of Oracle (ORCL) in Q2 2026, closing a stake of 20,000 shares — an estimated $2.94M sold.

Proem Advisors first reported a position in ORCL in Q4 2024 and held it in 6 quarters. The position peaked at $25.3M in Q3 2025. 3,545 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Proem Advisors reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
Proem Advisors sold 20,000 Oracle shares in Q2 2026, an estimated $2.94M.
Proem Advisors first reported a position in Oracle in Q4 2024 and held it in 6 quarters.
Proem Advisors's Oracle position peaked at $25.3M in Q3 2025.
3,545 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Proem Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.